HomeTagsNational Medical Products Administration

National Medical Products Administration

Biotechnology

RemeGen’s RC118 for Injection Targeting Claudin 18.2 in Patients with Gastric and Pancreatic Cancers Granted Two Orphan Drug Designations by U.S. FDA

PR Newswire - December 13, 2022

RemeGen Co., Ltd. , a commercial-stage biotechnology company, announced on December 7, 2022, that its latest antibody-drug conjugate (ADC), RC118 for injection, has been granted...

Healthcare

Sirtex Medical and Grand Pharmaceutical Group Limited Receive NDA approval of SIR-Spheres Y-90 Resin Microspheres

PR Newswire - February 10, 2022

Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced with its shareholder, Grand Pharmaceutical Group Limited, that SIR-Spheres® Y-90 resin microspheres have...